Until Labs is a Biotech company based in San Francisco, California. It has raised $106M in total funding. Latest round: Series A.
Until Labs funding overview
Until Labs is a Biotech company based in San Francisco, California. Until Labs has raised $106M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in September 2025. The round record for Until Labs runs through 2025; nothing later has been disclosed. Investors on record include Founders Fund, Lux Capital, Field Ventures. 3 distinct backers are named across the disclosed rounds.
Until Labs at a glance
Total raised
$106M
Latest round
Series A
Latest round date
September 2025
Industry
Biotech
Headquarters
San Francisco, California
Notable investors
Founders Fund, Lux Capital, Field Ventures
Frequently asked about Until Labs funding
How much has Until Labs raised?
Until Labs has raised $106M in total disclosed funding across the rounds on record.
Who has invested in Until Labs?
Founders Fund, Lux Capital, Field Ventures are named among the investors backing Until Labs.
What was the latest Until Labs funding round?
The most recent disclosed round is a Series A, announced in September 2025.
Where is Until Labs based?
Until Labs is based in San Francisco, California.
What sector does Until Labs operate in?
Until Labs is tracked under Biotech from San Francisco, California, with $106M in disclosed funding.
When did Until Labs last raise?
The last disclosed Until Labs round closed in September 2025 at Series A.
Totals shown for Until Labs aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in San Francisco and the investors behind them below.
